Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation

摘要

There is a paucity of contemporary data assessing the implications of atrial fibrillation (AF) on major adverse cardiovascular events (MACE) in patients with or at high‐risk for atherosclerotic disease managed in routine practice.